Details

Autor(en) / Beteiligte

• Pacheco-Navarro, Ana E.
• Rogers, Angela J.
• Stringer, Kathleen A
• Ghini, Veronica
• Luchinat, Claudio
• Stringer, Kathleen A.

Titel

The Metabolomics of Critical Illness

Ist Teil von

• Handbook of experimental pharmacology, 2023, Vol.277, p.367-384

Ort / Verlag

Switzerland: Springer International Publishing AG

Erscheinungsjahr

2023

Quelle

MEDLINE

Beschreibungen/Notizen

• Critical illness is associated with dramatic changes in metabolism driven by immune, endocrine, and adrenergic mediators. These changes involve early activation of catabolic processes leading to increased energetic substrate availability; later on, they are followed by a hypometabolic phase characterized by deranged mitochondrial function. In sepsis and ARDS, these rapid clinical changes are reflected in metabolomic profiles of plasma and other fluids, suggesting that metabolomics could one day be used to assist in the diagnosis and prognostication of these syndromes. Some metabolites, such as lactate, are already in clinical use and define patients with septic shock, a high-mortality subtype of sepsis. Larger-scale metabolomic profiling may ultimately offer a tool to identify subgroups of critically ill patients who may respond to therapy, but further work is needed before this type of precision medicine is readily employed in the clinical setting.